WallStreetZenWallStreetZen

NASDAQ: PACB
Pacific Biosciences Of California Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Pacific Biosciences Of California earnings were -$657.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PACB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$426.1M, down 18,070.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PACB reported annual earnings of -$309.9M, with 1% growth. The next PACB earnings date is Jul 30, 2025.

PACB earnings history

Current Revenue
$152.4M
Current Earnings
-$657.7M
Current Profit Margin
-431.7%

PACB Return on Equity

Current Company
-170.4%
Current Industry
7.5%
Current Market
31.3%
PACB's Return on Equity (-170.4%)... subscribe to Premium to read more.
High Return on Equity Performance

PACB undefined

Current Company
-51.8%
Current Industry
8.7%
PACB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PACB announces earnings.

PACB undefined

Current Company
-81.36%
Current Industry
9.1%
PACB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PACB vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PACB-$232.04M-$657.75MN/A-$2.28
SRDX-$1.76M-$19.86MN/A-$1.40
CTKB$8.03M-$11.25M+1,755.75%$16,603.78
BFLY-$53.30M-$64.70MN/A-$0.29
OFIX-$31.63M-$143.07MN/A-$3.69
View Top Medical Device Stocks

PACB earnings dates

Next earnings date
Jul 30, 2025

Pacific Biosciences Of California Earnings Reports & History FAQ

What were Pacific Biosciences Of California's earnings last quarter?

On PACB's earnings call on Invalid Date, Pacific Biosciences Of California (NASDAQ: PACB) reported Q1 2025 earnings per share (EPS) of -$1.44, up 396.55% year over year. Total PACB earnings for the quarter were -$426.08 million. In the same quarter last year, Pacific Biosciences Of California's earnings per share (EPS) was -$0.29.

If you're new to stock investing, here's how to buy Pacific Biosciences Of California stock.

When does Pacific Biosciences Of California report earnings?

The next PACB earnings call is Invalid Date. Add PACB to your watchlist to be reminded of Pacific Biosciences Of California's next earnings date.

Is Pacific Biosciences Of California profitable or losing money?

As of the last Pacific Biosciences Of California earnings report, Pacific Biosciences Of California is currently losing money. Pacific Biosciences Of California's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$657.75 million, a 121.54% increase year over year.

What was PACB's earnings growth in the past year?

As of Pacific Biosciences Of California's earnings date in Invalid Date, Pacific Biosciences Of California's earnings has grown year over year. PACB earnings in the past year totalled -$657.75 million.

What are Pacific Biosciences Of California's earnings expectations?

The current EPS estimate for Pacific Biosciences Of California's earnings report in Invalid Date is -$0.18.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.